24周抗阻运动对认知正常老年人阿尔茨海默病脑特征的影响:AGUEDA随机对照试验二次分析
该二次分析纳入90名认知正常老年人(72±4岁,58%女性),随机分为抗阻运动组(每周3次、每次60分钟)或等待列表对照组,干预24周。抗阻运动组厚度/体积AD特征较对照组降低(SMD -0.23),Aβ阳性者降低更明显(SMD -0.64),且该降低与执行功能改善相关,提示可能为适应性改变。
要点
- 24周抗阻运动使认知正常老年人AD厚度/体积特征降低,Aβ阳性者更明显。
- AD特征降低与执行功能及注意力/抑制控制改善相关,未发现中介效应。
- GMMD特征无显著组间差异,Aβ阴性者未见厚度/体积特征改变。
核心结论
- 24周抗阻运动后AD宏观结构特征降低可能与执行功能改善相关,尤其Aβ阳性老年人,可能反映适应性而非有害的脑改变。
研究设计与样本
- 单中心、两臂、单盲随机对照试验的二次分析,纳入90名认知正常老年人(72±4岁,58%女性),随机分为抗阻运动组(每周3次、每次60分钟,n=46)或等待列表对照组(n=44)。
主要发现
- 与对照组相比,抗阻运动组厚度/体积AD特征降低(SMD -0.23;95%CI -0.43至-0.02),GMMD特征无显著效应(SMD 0.08;95%CI -0.13至0.29)。
- Aβ状态调节效应:Aβ阳性者抗阻运动组厚度/体积特征降低大于对照组(SMD -0.64;95%CI -1.09至-0.18),Aβ阴性者未见效应。
- 厚度/体积与GMMD降低分别与执行功能及注意力/抑制控制改善相关;AD特征变化未中介认知结局。
关键数值与推荐
- 抗阻运动方案为每周3次、每次60分钟,持续24周。
- 主要结局为基于皮层和海马区域推导的厚度/体积及灰质平均弥散率(GMMD)AD特征。
- 调节因素包括年龄、性别、教育、多病共存、APOE ε4状态、Aβ状态及基线AD脑特征。
临床怎么用
- 对认知正常老年人,尤其Aβ阳性者,24周抗阻运动可能带来与执行功能改善相关的脑结构改变,支持运动作为可操作的非药物干预。
- 解读抗阻运动后AD脑特征降低时需结合Aβ状态和认知变化,避免简单视为有害萎缩。
局限性
- 本研究为二次分析,样本量90例,结果需在更大样本中验证。
- 干预24周,长期效应及临床硬终点(如痴呆发病)未评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brain imaging markers may help detect early cognitive decline and Alzheimer's disease (AD). Although exercise-related effects on AD-specific brain signatures remain unclear. OBJECTIVE: To examine the effects of a 24-week resistance exercise (RE) program on AD brain signatures in cognitively unimpaired older adults, to explore potential moderators and to assess associations with cognition, including mediation effects. METHODS: This secondary analysis of a single-site, two-arm, single-blinded randomized controlled trial included 90 participants (72 ± 4 years; 58% female) randomly assigned by a blind external researcher to an RE group (3 sessions/week, 60 min/session, n = 46) or a wait-list control group (CG, n = 44). T1- and diffusion-weighted MRI were acquired at baseline and post-intervention. Primary outcomes were thickness/volume and grey matter mean diffusivity (GMMD) signatures, derived from cortical and hippocampal regions. Moderators included age, sex, education, multimorbidity, apolipoprotein E ϵ4 status, amyloid beta (Aβ) status and baseline AD brain signatures. Secondary outcomes included cognitive function. Outcome measures and analyses were conducted by staff blinded to intervention assignment. RESULTS: Compared with the CG, the RE group showed a reduction in the thickness/volume signature (-0.23 standardized mean difference [SMD]; 95% CI, -0.43 to -0.02), but no effect on the GMMD signature (0.08 SMD; 95% CI, -0.13 to 0.29). Aβ-status moderated the effect, as Aβ-positive participants in the RE group showed a larger reduction in the thickness/volume signature than those in the CG (-0.64 SMD; 95% CI, -1.09 to -0.18), whereas no effect was observed in Aβ-negative participants. Thickness/volume and GMMD reductions were associated with improvements in executive function and attentional/inhibitory control, respectively. Changes in AD signatures did not mediate cognitive outcomes. CONCLUSION: Our findings suggest that reductions in the macrostructural AD signature following a 24-week RE program may reflect adaptive, rather than detrimental, brain changes, particularly in Aβ-positive older adults, as these changes were associated with improved executive function. TRIAL REGISTRATION: Registered on Clinicaltrials.gov (Identifier: NCT05186090).
引用
- Sanchez-Martinez J, Solis-Urra P, Fernandez-Gamez B, et al. Effects of a 24-week resistance exercise program on Alzheimer's disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial. Age Ageing. 2026. PMID: 41967036. doi:10.1093/ageing/afag086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。